(Add company comment from conference call, Q2 EPS forecast, share price). By Bill Berkrot. May 5 (Reuters) - Generic drugmaker Mylan NV, at the center of a high-stakes, three-way takeover battle, said on Tuesday it is fully committed to acquiring ...
Mylan Maintains Perrigo Push as First-Quarter Profit Falls Short
Mylan Profit Tops Estimates, Sales Misses